Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127294122 | 12729412 | 2 | F | 2016 | 20160906 | 20160909 | 20160914 | EXP | US-CELGENEUS-USA-2016091511 | CELGENE | 0.00 | F | Y | 63.56000 | KG | 20160914 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127294122 | 12729412 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | B201103 | 20785 | 150 | MG | CAPSULES | ||||||
| 127294122 | 12729412 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | A2142A | 21880 | 25 | MG | CAPSULES | QD | |||||
| 127294122 | 12729412 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | A2142A | 21880 | 15 | MG | CAPSULES | QD | |||||
| 127294122 | 12729412 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 60 MILLIGRAM | U | A2142A | 21880 | 10 | MG | CAPSULES | QOD | ||||
| 127294122 | 12729412 | 5 | C | KYPROLIS | CARFILZOMIB | 1 | Unknown | 3.5 MILLIGRAM | 0 | 60 | MG | UNKNOWN | |||||||
| 127294122 | 12729412 | 6 | C | VELCADE | BORTEZOMIB | 1 | Unknown | 0 | 3.5 | MG | UNKNOWN | ||||||||
| 127294122 | 12729412 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 127294122 | 12729412 | 8 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127294122 | 12729412 | 1 | Plasma cell myeloma |
| 127294122 | 12729412 | 2 | Plasma cell myeloma |
| 127294122 | 12729412 | 5 | Product used for unknown indication |
| 127294122 | 12729412 | 6 | Product used for unknown indication |
| 127294122 | 12729412 | 7 | Product used for unknown indication |
| 127294122 | 12729412 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127294122 | 12729412 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127294122 | 12729412 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127294122 | 12729412 | 1 | 20160804 | 0 | ||
| 127294122 | 12729412 | 2 | 20150817 | 0 | ||
| 127294122 | 12729412 | 3 | 201601 | 0 | ||
| 127294122 | 12729412 | 4 | 201602 | 0 |